Evaluation of [C-11]RTI-121 as a selective radioligand for PET studies of the dopamine transporter

被引:16
|
作者
Hume, SP
Luthra, SK
Brown, DJ
OpackaJuffry, J
Osman, S
Ashworth, S
Myers, R
Brady, F
Carroll, FI
Kuhar, MJ
Brooks, DJ
机构
[1] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,MRC CLIN SCI CTR,CYCLOTRON UNIT,NEUROSCI GRP,LONDON W12 0NN,ENGLAND
[2] RES TRIANGLE INST,DEPT ORGAN & MED CHEM,RES TRIANGLE PK,NC 27709
[3] NIDA,NEUROSCI BRANCH,ADDICT RES CTR,BALTIMORE,MD 21224
来源
NUCLEAR MEDICINE AND BIOLOGY | 1996年 / 23卷 / 03期
关键词
dopamine transporter; RTI-121; positron emission tomography;
D O I
10.1016/0969-8051(96)00019-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The cocaine analogue RTI-121 (3 beta-(4-iodophenyl)tropane-2 beta-carboxylic acid isopropyl ester), when labeled with carbon-11, was evaluated in rats as a potential PET ligand for the dopamine transporter. The compound gave in vivo striatum:cerebellum ratios that were similar to those obtained with the related ligand [C-11]RTI-55 (2 beta-(4-iodophenyl)tropane-2 beta-carboxylic acid methyl ester) but showed a much greater selectivity for the dopamine compared with the 5-HT uptake site, The results indicate that [C-11]RTI-121 could be used in preference to [C-11]RTI-55 in man. Experimentally, [C-11]RTI-121 has potential in the quantification of dopamine terminal function in rat models of disease, using a combination of autoradiography, postmortem sampling, and in vivo tomography.
引用
收藏
页码:377 / 384
页数:8
相关论文
共 50 条
  • [1] Quantification of dopamine transporter studies using carbon-11 labelled RTI-121 and PET.
    Lammertsma, AA
    Turjanski, N
    Hume, SP
    Luthra, SK
    Osman, S
    Piccini, P
    Brown, DJ
    Carroll, FI
    Brooks, DJ
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 426 - 426
  • [2] Characterization of [(125)~I]RTI-121 binding to dopamine transporter in vitro
    陈念航
    丁建花
    王幼林
    Acta Pharmacologica Sinica, 1997, (02) : 20 - 25
  • [3] Characterization of [I-125]RTI-121 binding to dopamine transporter in vitro
    Chen, NH
    Ding, JH
    Wang, YL
    Reith, MEA
    ACTA PHARMACOLOGICA SINICA, 1997, 18 (02): : 115 - 120
  • [4] [C-11]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease
    Guttman, M
    Burkholder, J
    Kish, S
    Wilson, A
    Houle, S
    NEUROLOGY, 1996, 46 (02) : 6089 - 6089
  • [5] [C-11]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: Implications for the symptomatic threshold
    Guttman, M
    Burkholder, J
    Kish, SJ
    Hussey, D
    Wilson, A
    DaSilva, J
    Houle, S
    NEUROLOGY, 1997, 48 (06) : 1578 - 1583
  • [6] [C-11] NNC-112, A SELECTIVE PET RADIOLIGAND FOR EXAMINATION OF EXTRASTRIATAL DOPAMINE D1 RECEPTORS
    HALLDIN, C
    FOGED, C
    KARLSSON, P
    SWAHN, CG
    ANDERSON, PH
    FARDE, L
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P122 - P122
  • [7] Synthesis, radiosynthesis and in vivo preliminary evaluation of [11C]LBT-999, a selective radioligand for the visualisation of the dopamine transporter with PET
    Dollé, F
    Emond, P
    Mavel, S
    Demphel, S
    Hinnen, F
    Mincheva, Z
    Saba, W
    Valette, H
    Chalon, S
    Halldin, C
    Helfenbein, J
    Legaillard, J
    Madelmont, JC
    Deloye, JB
    Bottlaender, M
    Guilloteau, D
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (04) : 1115 - 1125
  • [8] [C-11] FLB-457, A SELECTIVE PET RADIOLIGAND FOR EXAMINATION OF EXTRASTRIATAL DOPAMINE D2 RECEPTORS
    FARDE, L
    HALLDIN, C
    SUHARA, T
    NYBERG, S
    KARLSSON, P
    HOGBERG, T
    HALL, H
    SWAHN, CG
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P84 - P85
  • [9] MAPPING DOPAMINE TRANSPORTERS IN THE HUMAN BRAIN WITH NOVEL SELECTIVE COCAINE ANALOG [I-125] RTI-121
    STALEY, JK
    BOJA, JW
    CARROLL, FI
    SELTZMAN, HH
    WYRICK, CD
    LEWIN, AH
    ABRAHAM, P
    MASH, DC
    SYNAPSE, 1995, 21 (04) : 364 - 372
  • [10] [11C]LBT-999, a new high selective radioligand for PET examination of the dopamine transporter.
    Saba, W
    Chalon, S
    Valette, H
    Dolle, F
    Garreau, L
    Emond, P
    Halldin, C
    Deloye, JB
    Guilloteau, D
    Bottlaender, M
    NEUROIMAGE, 2004, 22 : T160 - T160